EPAZ Stock | News | Quote | Stock Forum | Tuesday, March 18,

New Post Public Reply Private Reply Replies (0) Message Board
Rosner
$EPAZ Epazz, Inc. EPAZ Company Overview 

Epazz, Inc. EPAZ Current Price and Quotes
Last Price 0.0004
Previous Close 0.0003 Open 0.0003
Daily Range 0.0004 - 0.0002 52wk Range 0.003 - 0.0002
Volume 610,496,131 Dividend N/A
Average Vol (3m) 64,926,551 Yield N/A

EPAZ Stock Message Board http://investorshangout.com/search?q=EPAZ&...mp;yt1=Go!

Last Updated: Tuesday, March 18, 2014 00:20:51 AM

Epazz, Inc. EPAZ

Company Updated Profile
Company Information

205 W. Wacker Dr.
Suite 1320
Chicago, IL 60606

Website: http://www.epazz.com
Phone: (312) 955-8161
Find us on:    

Epazz, Inc. EPAZ
Epazz Inc. is an enterprise-wide cloud software company that specializes in providing customized web applications to the corporate world, higher education institutions and the public sector. Epazz unique BoxesOS applications can create virtual communities for enhanced communication, provide information and content for decision-making, and create a secure marketplace for any type of commerce all through the medium of the Internet. Epazz is the answer to the increasing information technology dema...



Epazz, Inc. EPAZ
Financial Reportings and Disclosures

Reporting Status U.S. Reporting: SEC Filer
Audited Financials Not Available
Latest Report Sep 30, 2013 10-Q
CIK 0001335239
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data

SIC - Industry Classification 7372 - Prepackaged software
Business Status SPAC a/o Jun 18, 2008
Incorporated In: IL, USA
Year of Inc. 1999
Employees 8 a/o Mar 22, 2013
Company Officers/Contacts

Shaun Passley CEO, CFO, President
Company Directors

Shaun Passley Chairman
Service Providers

Auditor/Accountant
M&K CPAS, PLLC
4100 North Sam Houston Pkwy W
Houston, TX, 77086
United States

Legal Counsel
The Loev Law Firm, PC
6300 West Loop South
Bellaire, TX, 77401
United States

Investor Relations Firm
Not Available

Epazz, Inc. EPAZ
EPAZ Security Details

Share Structure

Market Value1 $1,387,343 a/o Mar 17, 2014
Shares Outstanding 3,468,358,708 a/o Nov 18, 2013
Float 251,394,176 a/o Jul 10, 2013
Authorized Shares 6,000,000,000 a/o Jul 10, 2013
Par Value  0.01
Shareholders

Shareholders of Record 54 a/o Jul 10, 2013
Security Notes

Capital Change=shs decreased by 1 for 10 split. Pay date=08/24/2010.
Short Selling Data

Short Interest 5,583 (100%)
Feb 28, 2014
Significant Failures to Deliver  No
Transfer Agent(s)

Island Stock Transfer

Epazz, Inc. EPAZ Financials
Period Ending Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue 1,193 736 705
Cost of Revenue - - -
Gross Profit 1,193 736 705
Operating Expenses

Research and Development - - -
Sales, General and Admin. 2,364 637 405
Non-Recurring Items 3 82 -
Other 275 177 106
Operating Income (1,449) (161) 194
Income From Continuing Operations

Add'l Income/Expense Items (137) - -
Earnings Before Interest and Tax (1,586) (161) 194
Interest Expense 320 176 73
Earnings Before Tax (1,907) (337) 121
Income Tax - - -
Minority Interest - - -
Equity Earnings Unconsolidated Subsidiary - - -
Net Income Cont. Operations (1,907) (337) 121
Non Recurring Events

Discontinued Operations - - -
Extraordinary Items - - -
Effect of Accounting Changes - - -
Other Items - - -
Net Income (1,907) (337) 121
Preferred Stock and Other Adjustments - - -
Net Income Applicable to Common Shareholders (1,907) (337) 121

Epazz, Inc. EPAZ Recent News

Mar 6, 2014 Epazz Expects to Add 50% to Revenue Stream; Signs Purchase Agreement to Acquire Contact Center Software Company
Feb 27, 2014 Epazz Expects to Add 30% Increase to Recurring Revenue Stream; Signs Letter of Intent to Acquire Software Company Used by Colleges
Feb 20, 2014 Epazz: Intellisys Renews Over 90 Percent of Support Plans and Launches New Version of Intellisys SystemVIEW Called SystemVIEW Cloud
Feb 13, 2014 Epazz K9Bytes Renewed Over 90% of Our Support Plans
Feb 6, 2014 Epazz Agreed to Acquire Small Business Software Company; Epazz Expects to Add 5% Increase to Recurring Revenue Stream
Jan 31, 2014 Epazz Expects to Add 15% Increase to Recurring Revenue Stream; Signs Letter of Intent to Acquire Help Desk Software Company
Jan 8, 2014 Epazz K9 Bytes: New 24/7/365 Support Plans Cause Renewal Revenue to Increase Over 40%
Dec 19, 2013 Epazz's K9 Bytes Subsidiary Launches K9Kloud.com E-Commerce Website and the Future Home for K9Bytes Cloud Services


EPAZ Epazz, Inc. Research DD Guide

Stock Message Board http://investorshangout.com/search?q=EPAZ&...mp;yt0=Go!
Stock Quote http://www.otcmarkets.com/stock/EPAZ/quote
Stock Chart http://www.otcmarkets.com/stock/EPAZ/chart
Company Info http://www.otcmarkets.com/stock/EPAZ/company-info
Recent News http://www.otcmarkets.com/stock/EPAZ/news
Financials http://www.otcmarkets.com/stock/EPAZ/financials
Filings and Disclosure http://www.otcmarkets.com/stock/EPAZ/filings
Short Sales http://www.otcmarkets.com/stock/EPAZ/short-sales
Insider Disclosure http://www.otcmarkets.com/stock/EPAZ/insider-transactions
Research Reports http://www.otcmarkets.com/stock/EPAZ/research
Summary http://finance.yahoo.com/q?s=EPAZ
Historical Prices http://finance.yahoo.com/q/hp?s=EPAZ+Historical+Prices
Interactive Chart http://finance.yahoo.com/echarts?s=EPAZ
Basic Chart http://finance.yahoo.com/q/bc?s=EPAZ+Basic+Chart
Basic Tech. Analysis http://finance.yahoo.com/q/ta?s=EPAZ+Basic+Tech.+Analysis
Headlines http://finance.yahoo.com/q/h?s=EPAZ+Headlines
Press Releases http://finance.yahoo.com/q/p?s=EPAZ+Press+Releases
Company Profile http://finance.yahoo.com/q/pr?s=EPAZ+Profile
Key Statistics http://finance.yahoo.com/q/ks?s=EPAZ+Key+Statistics
Industry http://finance.yahoo.com/q/in?s=EPAZ+Industry
Major Holders http://finance.yahoo.com/q/mh?s=EPAZ+Major+Holders
Insider Transactions http://finance.yahoo.com/q/it?s=EPAZ+Insider+Transactions
Insider Roster http://finance.yahoo.com/q/ir?s=EPAZ+Insider+Roster
Income Statement http://finance.yahoo.com/q/is?s=EPAZ
Balance Sheet http://finance.yahoo.com/q/bs?s=EPAZ
Cash Flow http://finance.yahoo.com/q/cf?s=EPAZ+Cash+Flow&annual
Nasdaq http://www.nasdaq.com/symbol/EPAZ
Market Watch http://www.marketwatch.com/investing/stock/EPAZ
Bloomberg http://www.bloomberg.com/quote/EPAZ:US
Morningstar http://quotes.morningstar.com/stock/s?t=EPAZ
Bussinessweek http://investing.businessweek.com/research/st...icker=EPAZ
Barchart http://www.barchart.com/quotes/stocks/EPAZ
OTC Short Report http://otcshortreport.com/index.php?index=EPAZ
Investopedia http://www.investopedia.com/markets/stocks/EPAZ/?wa=0

List of all stock message boards and tickers for OTC BB Pinks & Penny Stocks http://investorshangout.com/board?categoryid=OTC
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 34

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 35

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 24

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 37

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 35

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

Man Group PLC Highlights Its Strategic Disclosures on Tritax REIT

Updated Category News Views 148

Strategic Position Disclosure by Man Group PLC Man Group PLC is actively sharing its significant interests in the securities market, particularly focusing on its involvement with Tritax Big Box REIT plc. As a key player in the investment landscape, this disclosure marks an important step for the company regarding its strategic holdings. Key Information Pertaining to the...

Continue Reading
TalentLMS and Epignosis Lead the Way in GDPR Compliance

Updated Category News Views 720

TalentLMS and Epignosis Set the Standard for GDPR Compliance TalentLMS, along with its parent company Epignosis, has continuously led the way in providing a fully compliant Learning Management System (LMS) with regards to the General Data Protection Regulation (GDPR). Recent developments affirm that TalentLMS remains the only LMS globally to uphold its commitment to this...

Continue Reading
Zillow and Esusu Forge New Path to Boost Renters' Credit Scores

Updated Category News Views 283

Building Credit for Renters with Zillow and Esusu The recent collaboration between Zillow and Esusu marks a significant step towards empowering renters across the country to build their credit. This partnership allows any renter to report their on-time rent payments, significantly enhancing their credit profiles, for just $20 a year. How the Partnership Works Starting...

Continue Reading
iCrowdNewswire Leverages DeepL for Enhanced Global Communication

Updated Category News Views 121

iCrowdNewswire Enhances Multilingual Capabilities iCrowdNewswire, a prominent international press release distribution company, has embarked on a transformative journey to improve its multilingual services through the introduction of the DeepL API. The integration of DeepL's cutting-edge language AI technology has significantly boosted iCrowdNewswire’s ability to...

Continue Reading
Celebrating Excellence: Top Surgeons Recognized in Endocrine Care

Updated Category News Views 82

Exceptional Recognition for Leading Surgeons in Endocrine Surgery Dr. Jim Norman and Dr. Gary Clayman Acknowledged as Premier Specialists The Hospital for Endocrine Surgery is proud to announce that two of its distinguished surgeons, Dr. Jim Norman and Dr. Gary Clayman, have been honored in the prestigious Castle Connolly Top Doctors list for 2025. This remarkable...

Continue Reading